Read + Share
Amedeo Smart
Independent Medical Education
Juric D, Islam KN, Gkotinakou IM, Zheng A, et al. CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer. Cancer Res 2026 Jul 2. doi: 10.1158/0008-5472.CAN-25-1859.PMID: 42391342
Email
LinkedIn
Privacy Policy